ATP7B and Wilson disease: In recent years, liver-directed adeno-associated virus (AAV) vector-based gene therapies have shown great potential for the treatment of WD, and several AAV-mediated deliveries of human ATP7B (hATP7B) into mouse liver have proven the effectiveness in rescuing hepatic Cu homeostasis in WD mouse models.28